Literature DB >> 1283993

Comparison of various assay systems for prostate-specific antigen standardization.

M Kuriyama1, S Akimoto, H Akaza, Y Arai, M Usami, K Imai, Y Tanaka, H Yamazaki, Y Kawada, K Koiso.   

Abstract

To avoid confusion between serum prostate-specific antigen (PSA) values among various assay systems, clinical studies on the possibility of conversion among detection values were performed. The assay kits used for the PSA comparisons were MARKIT-F PA, MARKIT-M PA, EIKEN PA, PA test WAKO, Ball ELSA PSA, E-Test Tosoh II PA, PROS-CHECK PSA, DELFIA PSA and TANDEM-R PSA. Using each kit, the standards attached to each assay system were detected, and 142 sera samples from benign hypertrophies or prostate cancers were assayed for serum PSA values. By detecting the standards for each kit, slopes were obtained which were almost identical to those obtained from original assay system. The coefficients of correlation among the PSA detection systems, using patients' sera, were very high, and linear regression lines were also obtained. The results suggest that almost identical serum PSA values may be detected either by multiplying by a coefficient to bring it to the standard or using the conversion formula.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283993

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancer.

Authors:  K Akakura; S Akimoto; J Shimazaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Chemotherapy for endocrine-therapy-refractory prostate cancer.

Authors:  S Akimoto; T Ohki; K Akakura; M Masai; J Shimazaki
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.